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What are the novel findings of this work? 
Early sonographic assessment at (5-7 postmenstrual weeks) can predict PAS stage in women at high 
risk for these anomalies.COS1 and implantation of the gestational sac “in the niche” of the prior CS 
scar and “below the line” were independently associated and predictive of severe stages of PAS in 
the third trimester of pregnancy. 
 
What are the clinical implications of this work? 
first trimester US can help in the risk stratification of women affected by PAS and it is able to identify 
a large proportion of women who will be affected by the most severe types of these anomalies. COS1 
and implantation of the gestational sac “in the niche” and “below the line” were independently 
associated with adverse surgical outcome.
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Objective: To explore the role of early first trimester ultrasound at 5-7 postmenstrual weeks of 
gestation in predicting sonographic staging of placenta accreta spectrum (PAS) and to elucidate 
whether integrating first trimester assessment with ultrasound staging of PAS can predict surgical 
outcome in women at risk for PAS.  
Methods: Secondary analysis of prospectively collected data of women who had at least one previous 
caesarean delivery (CD) or uterine surgery and placenta previa for whom early (5-7 weeks of 
gestation) ultrasound images could be retrieved. The relationship between gestational sac position 
and prior CD scar was assessed using classifications by Cali et al. (cross-over COS), Kaelin Agten et 
al. (“on the scar” vs “in the niche” implantation) and Timor-Tritsch et al. (“above the line” vs “below 
the line” implantation) by two different examiners blinded to the final diagnosis and clinical outcome. 
Primary aim of the study was to explore the strength of association and predictive accuracy of first 
trimester ultrasound in predicting PAS stage. Secondary aim was to elucidate whether integration of 
first trimester ultrasound with PAS staging can predict surgical outcome. Logistic regression and area 
under the curve analyses were used to analyse the data. 
Results: One hundred and eighty-seven women were included. Of these ,79.6% (95% CI 67.1-88.2) 
had COS1, 94.4% (95% CI 84.9-98.1) “in the niche” and 92.6% (95% CI 82.4-97.1) “below the line” 
implantation confirmed to be affected by PAS3 in the third trimester of pregnancy. On multivariate 
logistic regression analysis, COS1 (OR: 7.9 (95% CI 4.0-15.5; p<0.001), “in the niche” (OR: 29.1, 
95% CI 8.1-104; p<0.001) and “below the line” (OR: 38.1, 95% CI 12.1-121; p<0.001) implantations, 
however, neither parity (p= 0.4), nor the number of prior CDs (p= 0.5) were independently associated 
with PAS3. When translating these figures in a diagnostic model, either COS1 (AUC: 0.94, 95% CI 
0.91-0.97), or implantation “in the niche” (AUC: 0.92, 95% CI 0.89-0.96) or “below the line” (AUC: 
0.92, 95% CI 0.88-0.96) had a high predictive accuracy for PAS3. Adverse surgical outcome was 
more common in women with COS1 (p<0.001), implantation “in the niche” (p<0.001) and “below 
the line” (p<0.001) then those without them.)  On multivariate logistic regression analysis, ultrasound 
diagnosis of PAS3 (OR: 4.3, 95% CI 2.1-17.3), COS1 (OR: 7.9, 95% CI 4.0-15.5; p<0.001), “in the 
niche” (OR: 29.1, 95% CI 8.1-104; p<0.001) and “below the line” (OR: 7.9, 95% CI 4.0-15.5; 
p<0.001) implantations were independently associated with adverse surgical outcome. When 
combining the three imaging methods, we identified, an area we call “high-risk-for-PAS Triangle” 
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which may enable an easy visual perception and application of the three methods to prognosticate the 
risk for CSP and PAS, although it requires validation in further large prospective studies.    
Conclusion: Early first trimester sonographic assessment of pregnancies after CDs can reliably 
predict ultrasound staging of possible PAS. Integrating first with second and third trimester 
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INTRODUCTION 
Placenta accreta spectrum (PAS) disorders encompasses a heterogenous group of conditions 
characterized by an abnormal adhesion to, and invasion of trophoblastic tissue through the 
myometrium and uterine serosa1-4. Although the natural history of PAS disorders has not been 
completely elucidated yet, placenta previa and prior caesarean delivery (CD) or uterine surgery 
represents its main risk factors4,5. Furthermore, recent evidence supports the role of caesarean scar 
pregnancy (CSP) as an early precursor of PAS6-9. 
Advances in prenatal imaging have led to an increase of the detection rate of PAS, which in turn has 
improved their surgical outcome10-15. We published recently on prenatal staging of PAS based upon 
a number of ultrasound (US) signs in women at high risk for these disorders16.  However, this staging 
system did not take into account the role of first trimester US findings.  
Early first trimester (5-7 postmenstrual weeks of gestation) US has been recently shown to predict 
the possibility of developing PAS in women at high risk for this anomaly, thus supporting the role of 
early sonographic evaluation as a potential early predictor of surgical complications of PAS17-21. 
The primary aim of this study was to elucidate whether retrospective early first trimester assessment 
(at 5-7 postmenstrual weeks of gestation) can correlate with US staging of PAS in the second half of 
pregnancy. Secondary aim was to explore whether combining first trimester assessment in the 








This is a secondary retrospective analysis of a previous, prospective longitudinal study on the 
diagnostic performance of US in detecting PAS including women with placenta previa and at least 
one prior CD or uterine surgery between 2009 and 201822. All women had a longitudinal bimonthly 
assessment in the second and third trimester of pregnancy as per local guidelines, in order to detect 
PAS. STROBE guidelines were followed23. 
Ultrasound assessment was performed via transvaginal and transabdominal US in all cases. All 
examinations were originally performed using a 4.0-6.0 MHz curved transabdominal or 5.0-7.0 MHz 
transvaginal transducers (GE Voluson® 730, General Electrics and Samsung WS80A with Elite, 
Samsung); when using Colour Doppler US the pulsed rate frequency (PRF) was initially set at 1.3 
KHz but it was lowered in order to identify the presence of placental lacunar flow.  
 
According to the distribution of the classical ultrasound signs of PAS, each case was labelled 
according to our previously proposed US staging:16,24 
PAS0: Placenta previa with no US signs of invasion or placenta previa with placental lacunae but no 
evidence of abnormal uterine-bladder interface (loss of the clear zone and/or bladder wall 
interruption). 
PAS1: Presence of at least two of the following ultrasound signs: 
• Placental lacunae 
• Loss of the clear anechoic zone of the myometrium 
• Bladder wall interruption 
PAS2: PAS1 + uterovescical hypervascularity 
PAS3: PAS1/PAS2 + evidence of increased vascularity in the inferior part of the lower uterine 
segment extending in the parametrial region. 
 
Early first trimester ultrasound images from 5 to 7 postmenstrual weeks of gestations were retrieved 
from the computerized database of each referring hospital and the relationship between the gestational 
sac and the prior CD scar was assessed according to the classification reported by Cali et al. (“cross-
over sign”, [COS])17,18, Kaelin Agten et al. (“on the scar” vs. “in the niche” implantation)19 and  
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Timor-Tritsch et al. (“below the line” vs. “above the line” implantation)20 by two different examiners 
blinded to the final diagnosis and clinical outcome. A detailed description of first trimester assessment 
of the relationship between the prior CS and the gestational sac according to the three different 
classification system is reported in Appendix 1 and Figure 1 A, B,C and D. 
 
Clinical management of PAS disorders 
All women with a prenatal and intra-operative diagnosis of PAS were treated with caesarean 
hysterectomy and pre-operative temporary occlusion of internal iliac arteries using balloon 
catheters25-27. For those cases showing sonographic evidence of PAS and no clear placental invasion 
at direct visualization, after the delivery of the fetus and clamping of the cord, the balloon catheters 
were inflated and an attempt to expel the placenta performed.  This was aided by administering intra-
venous carbetocin ( Duratocin, Ferring, Italy) and  controlled cord traction. In the event of failed 
placental detachment, hysterectomy was performed, preserving the adnexa and leaving the placenta 
in situ. Conversely, for cases showing placental tissue protruding through the uterine serosa, a 
longitudinal incision on the uterine fundus was performed to deliver the fetus, followed by cesarean 
hysterectomy without any attempt to remove the placenta.   
Finally, women presenting with placenta previa with no US evidence of PAS had CD with an incision 
performed on the lower uterine segment without the use of interventional radiology techniques. The 
multidisciplinary team remained the same through the study period. 
No attempt was made to leave the placenta in situ in order to delay surgery and women undergoing 
conservative surgical technique (including TRIPLE-P or one step conservative surgery) excluded 
from the study not to bias the analysis.   
Prenatal pregnancy management, timing of deliveries and surgical technique were independent of the 
third US grading of PAS or first trimester type of implantation. 
 
Data analysis 
In a sample of women diagnosed with PAS disorder ranging from PAS-0 to PAS-3, we investigated 
the relationship between first trimester implantation of the gestational sac, defined according to the 
three classifications system reported by Cali et al.17,18 (“cross-over sign”, [COS]), Kaelin Agten et 
al.19 (“on the scar” vs. “in the niche” implantation) and  Timor-Tritsch et al.20 (“below the line” vs. 
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“above the line” implantation) and the following clinical variables: (1) a third-trimester diagnosis of 
PAS-3 (versus lower PAS grades); (2) Adverse surgical events occurring during delivery.  The latter 
contained (a composite outcome including: (a) estimated blood loss >1500 mL; (b) transfusion of >5 
units of red blood cells, platelets and fresh frozen plasma; (c) surgical complications; (d) admission 
to Intensive Care Unit). 
The potential association between all recorded gestational and ultrasound parameters and the two 
outcomes were first evaluated with standard univariate analyses (chi-squared test for categorical 
variables; Kruskal-Wallis test for continuous variables), and then fitting multiple logistic regression 
models. A stepwise forward process was used for all models building, and the following criteria were 
adopted for covariates selection: (a) p<0.05 at univariate analyses; (b) clinical significance; (c) COS 
type (treated as an ordinal variable), cesarean scar implantation (categorized into “in the niche” versus 
“on the scar” or “normal") or site of implantation (categorized into ”below” versus “above the line”) 
forced to entry in separate models as mutually exclusive variables, due to their overlapping clinical 
significance. A total of three and four logistic models were built for PAS-3 and adverse surgical 
outcome, respectively. As parity status and number of previous CD were collinear, we chose to 
include the most relevant covariate from a clinical point of view, namely number of prior CD in the 
models predicting PAS-3. Moreover, to reduce the potential overfitting due to the limited number of 
women experiencing an adverse surgical outcome (n=22), the number of covariates for this outcome 
was limited to three in every phase of model fitting28. The goodness-of-fit was then checked using 
Hosmer-Lemeshow test, and the predictive power assessed through C-statistics (area under the 
Receiving Operator Curve - AUC). For each outcome, any improvement in model performance was 
assessed from change in the AUC. Standard post-estimation tests were used to check the validity of 
all final models, performing multicollinearity and influential observation analyses (using 
standardized residuals, change in Pearson and deviance chi-square). 
Additionally, we estimated the potential of: (a) COS-1, (b) “in the niche” and (c) “below the line” 
implantation to predict both outcomes computing summary estimates of sensitivity, specificity, 
positive and negative predictive values (PPV and NPV), positive and negative likelihood ratios (LR+ 
and LR-), and diagnostic odds ratios (DOR). 95% Confidence Intervals (CI) for specificity and 
sensitivity and for PPV and NPV were computed according to the efficient-score method (corrected 
for continuity) described by Newcombe29. 
This article is protected by copyright. All rights reserved.
 
Finally, we tested the differences in adverse surgical outcome, estimated blood loss (EBL), 
transfusion of packed red blood cells (PRBC), blood products (BP), platelets, fresh frozen plasma 
(FFP) between women presenting with COS1 or “in the niche” implantation in the first and PAS3 in 
the third trimester compared to those showing COS2 or “in the scar” in the first and PAS3 in the third 
trimester of pregnancy.  Statistical significance was defined as a two-sided p-value <0.05 for all 
analyses, which were carried out using Stata, version 13.1 (Stata Corp., College Station, Texas, USA, 
2013). 
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RESULTS 
One hundred and eighty-seven women with placenta previa and at least one prior CD or uterine 
surgery from which early (5-7 postmenstrual weeks of gestation) could be retrieved were included in 
the analysis. General characteristics of the study population are reported in Table 1. Mean maternal 
age was 32.8±5.1 years, while the gestational age at birth was 35.3±1.7 weeks. Hysterectomy was 
performed in all women affected by PAS1-3 compared to none of those presenting with PAS0; 
likewise, none of the included cases was treated leaving the placenta in situ or partially resective 
surgical techniques (Table 1).  
 
According to early first trimester US, 41.7% (95% CI 34.9-48.978/187) of cases were labelled as 
COS0, 29.4% (95% CI 23.4-36.3; 55/187) as COS1 and 28.9% (95% CI 22.9-35.8; 54/187) as COS-
2. 19.3% (95% CI 14.2-25.5; 36/187) of cases showed implantation of the gestational sac “on the 
scar”, while 39.0% (95% CI 32.3-46.2; 73/187) were “in the niche” implantations. (Table 1). Finally, 
40.1% (95% CI 33.4-47.3; 75/187) of cases showed implantation of the sac “below”, while 58.9% 
(95% CI 52.7-66.7; 112/187) “above” the line. When assessing the sonographic staging of PAS, 
41.7% (95% CI 34.9-48.9; 78/187) of women were labelled as PAS0, 20.9% (95% CI 15.7-27.2; 
39/187) as PAS1, 8.6% (5.6-13.5; 16/187) as PAS2 and finally, 28.9% (95% CI 22.9-35.8; 54/187) 
as PAS3 (Table 1).  
   
Table 2 showed the distribution of the different types of COS implantation according to the third 
trimester sonographic staging of PAS.  All women with COS0 on early first trimester ultrasound were 
labelled as PAS0 in the third trimester. Conversely, only 7.7% (95% CI 2.7-20.3; 3/39) of cases 
labelled as COS-1 in the first trimester were found to be PAS3 in the third trimester of pregnancy 
compared to 92.3% (95% CI 79.7-97.4; 36/39) of COS2 (p<0.01). More importantly, 79.6% (95% CI 
67.1-88.2; 43/54) of cases showing COS1 implantation were found to be PAS3 on third trimester US, 
compared to 20.4% (95% CI 11.8-32.9; 11/54) of cases showing COS2 (p<001). 
When assessing the distribution of the “in the niche/on the scar” implantation, 23.1% (95% CI 12.7-
38.3; 9/39) of women showing implantation of the gestational sac “in the niche” of the prior CDwere 
PAS1 on third trimester US compared to 76.9% (95% CI 61.7-87.4; 30/39) of those showing 
implantation “on the scar”. Conversely, 94.4% (95% CI 84.9-98.1; 51/54) of women having 
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implantation of the gestational sac “in the niche” were PAS3 compared to only 5.6% (95% CI 1.9-
15.1; 3/54) of those implanted “on the scar” (p<0.01). Finally, all cases with PAS3 had implantation 
of the center of the gestational sac “below the line”, compared to only 18.0% (95% CI 9.0-32.7; 7/39) 
and 87.5% (95% CI 64.0-96.5; 14/16) with PAS2 and PAS3 respectively (Table 2). 
 
On multivariate logistic regression analysis, after adjusting for all potential confounders, COS1 
implantation, but not parity (p=0.4) or the number of prior CS (p=0.5) was independently associated 
with PAS3 with an OR of 7.9 (95% CI 4.0-15.5; p<0.001). Likewise, implantation “inthe niche” (OR: 
29.1 (95% CI 8.1-104; p<0.001) and “below the line” (OR: 38.1, 95% CI 12.1-121; p<0.001) were 
also associated with PAS3 (Table 3). When translating these figures in a diagnostic model, either 
COS1 (AUC: 0.94, 95% CI 0.91-0.97), implantation “in the niche” (AUC: 0.92, 95% CI 0.89-0.96) 
and “below the line” (AUC:  0.92, 95% CI 0.88-0.96) had a high predictive accuracy for PAS3. The 
three models showed a similar predictive accuracy in terms of sensitivity and specificity (Figure 2, 
Table 6). 
 
Adverse surgical outcome complicated 11.8% (95% CI 7.9-17.2; 22/187) pregnancies. Mean 
maternal age was higher (35.7±3.5 vs 32.4±5.1 years; p= 0.004) while gestational age at surgery lower 
(34.1±1.9 vs 35.5±1.6 weeks; p<0.001) in women experiencing compared to those not experiencing 
adverse surgical outcome. Likewise, the incidence of placenta percreta (95.4% vs 29.7%; p<0.001) 
and PAS3 stage on US (81.8% vs 21.8%; p<0.001) were higher in pregnancies complicated by 
adverse surgical outcome. 
When exploring the distribution of the different first trimester US signs of abnormal gestational sac 
implantation, COS1 implantation was more common in women experiencing compared to those not 
experiencing adverse surgical outcome (86.4% vs 21.8%; p<0.001), while there was no difference in 
the distribution of either COS0 and COS2 implantation between the two groups (Table 4). Likewise, 
women experiencing adverse surgical outcome had a higher incidence implantation of gestational sac 
“in the niche” compared to that “on the scar” of the prior CD (94.4% vs 4.6%; p<0.001) and “below” 
compared to “above” the line (90.9% vs 9.1%, p<0.001) (Table 4). 
On multivariate logistic regression analysis, after adjusting for all potential confounders, PAS3 on 
US (OR: 4.3, 95% CI 2.1-17.3), COS1 (OR: 7.9, 95% CI 4.0-15.5; p<0.001), implantation “in the 
This article is protected by copyright. All rights reserved.
 
niche” of the prior CS (OR: 29.1, 95% CI 8.1-104; p<0.001) and “below the line” (OR: 6.6 (95% CI 
3.9-16.2; p<0.001) were independently associated with adverse surgical outcome (Table 5). When 
translating these figures in a diagnostic model, either COS1 (AUC: 0.88, 95% CI 0.81-0.95), 
implantation “in the niche” (AUC: 0.871, 95% CI 0.81-0.93) and “below the line” (AUC: 0.87, 95% 
CI 0.82-0.93) had a similar high diagnostic accuracy for adverse surgical outcome (Figure 3, Table 
7). 
Finally, we tested the differences in adverse surgical outcome, EBL, transfusion of PRBC, BP, 
platelets and FFP between women presenting with COS1 or “in the niche” implantation in the first 
and PAS3 in the third trimester compared to those showing COS2 or “in the scar” in the first and 
PAS3 in the third trimester of pregnancy. The occurrence of adverse surgical outcome was higher in 
women with COS1-PAS3 compared to COS2-PAS3; likewise, mean EBL (p=0.0048), BP (p= 0.044) 
and PRBC transfused (p= 0.019) were higher in women with COS1-PAS3 compared to those with 
COS2-PAS3; while it was not possible to perform the comparison between women with “in the 
niche”-PAS3 vs “on the scar” PAS3 because only three women had “in the niche”-PAS3 
implantation.  (Table 8). 
  




The findings from this study show that retrospective early sonographic assessment at (5-7 
postmenstrual weeks)can predict PAS stage in women at high risk for these anomalies. COS1 and 
implantation of the gestational sac “in the niche” of the prior CS scar and “below the line” were 
associated and predictive of severe stages of PAS in the third trimester of pregnancy. Conversely, 
COS2, implantation “on the scar” and “above the line” were associated with less severe types of PAS. 
COS1, implantation “in the niche” and “below the line” were independently associated with adverse 
surgical outcome in women with PAS. Finally, retrospective first trimester US showed an overall 
good predictive accuracy for adverse surgical outcome. 
 
Strengths and limitations 
This is the first study exploring the role of first trimester US in predicting PAS stage.  
Large sample size, longitudinal and blinded assessment of the included cases from the first trimester 
of pregnancy until birth represent the major strengths of the study. Furthermore, we explored the role 
of both the previously published types of first trimester assessment (COS and “in the niche/on the 
scar” implantation) in predicting PAS stage and surgical outcome. Finally, all cases affected by PAS 
were managed by the same multidisciplinary team and treated with hysterectomy, thus reducing the 
risk of bias related to operator’s experience and type of surgical approach adopted.  
The main limitation of the study is by the fact that we did not explore whether the application of first 
trimester assessment could affect prenatal management and the prognosis of these pregnancies, since 
the study is a secondary retrospective analysis.  
 
Comparison with previous studies 
Previous studies have tried to correlate implantation of the gestational sac on first trimester ultrasound 
and risk of PAS disorders30-34.Vial et al.30 proposed two types of implantation types of in women 
affected by CSP: the first, implantation “on the scar” and the second “deep in the cesarean scar 
defect”. Likewise, Comstock et al31, in a small series of women with previous CS and confirmed 
PAS, reported that anterior low implantation of the gestational sac was the most common finding at 
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first trimester US and the same findings were reported in the study by Ballas et al.32 although the 
included cases were scanned at later gestational ages (8.5-14 weeks).  
Naji et al.33 assessed the relationship between the location of the gestational sac and the internal 
cervical os at 12 weeks of gestation and found that cases where the sac crossed the scar the pregnancy 
resulted in placenta previa and postpartum hemorrhage.  Finally, Rac et al.34 reported that a smallest 
myometrial thickness on 1st trimester US significantly improved detection rate of PAS.  
 
Implications for clinical practice and research 
One of the major challenges when counseling women with a diagnosis of PAS on US is the lack of 
objective prenatal predictors of surgical outcome.  
Histopathological assessment of the depth of placental invasion is retrospective and it cannot be used 
prospectively at the time of prenatal diagnosis35-38. Furthermore, different degrees of placental 
invasion can co-exist in the same uterus26. Finally, there might be high variability in the surgical 
outcome even in women presenting with the same depth of placenta invasion16,25,36. Topography of 
placental invasion has been recently reported to be a reliable predictor of surgical outcome in women 
with PAS irrespective of the depth of placental invasionwith Invasions in the inferior third of lower 
uterine segment, posterior bladder and parametria carrying a higher risk of surgical morbidity37,38. 
However, despite its clinical relevance, assessment of the topography of placental invasion has not 
yet been consistently reported on ultrasound. 
 
In view of the recently reported association between CSP and PAS, we have recently suggested that 
women with a prior CS or uterine surgery should undergo early sonographic assessment in order to 
detect CSP21. It is collective author’s’ opinion that an accurate clinical and sonographic evaluation of 
a pregnancy after a previous CS can facilitate not only timely counseling, but also, if needed, 
gestational age-appropriate, individualized pregnancy management21.  However, the effect of such 
screening program on costs for national health services should be balanced against its efficacy in 
improving the outcome of these women and may pose ethical dilemmas especially when CSP is 
detected in asymptomatic women. 
The findings from this study showed that first trimester US can help in the risk stratification of women 
affected by PAS and it is able to identify a large proportion of women who will be affected by the 
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most severe types of these anomalies. Based upon the findings from the present study, we proposed 
a new imaging assessment of the relationship between the gestational sac and the prior CS scar aiming 
at stratifying the risk for PAS in these women.  When combining the three imaging methods and 
placing the defining coordinates of the COS and the “above and below the uterine midline” as well 
as the “on the scar” and “in the niche” on a sagittal US image of the uterus, we identified, an area we 
call “high-risk-for-PAS Triangle” (Figure 4).  If the centre of the gestational sac is “in the niche” the 
pregnancy is high risk for PAS. This diagram may enable an easy visual perception and application 
of the three methods to prognosticate the risk for CSP and PAS, although it requires validation in 
further large prospective studies. Ideally, such studies would require different ultrasound 
examinations during the early first trimester in order to confirm a viable CPS, in view of the higher 
risk of embryonic demise in early pregnancy, and a comprehensive assessment of the inter-and intra-
observer variability of this sign in order to test its applicability in clinical practice.   
 
Conclusions 
This study demonstrates that early sonographic assessment (at 5-7 postmenstrual weeks of 
pregnancies after previous CDs and uterine surgeries) can predict PAS stage and surgical outcome. 
The findings of this study highlight the need for large prospective studies aimed at exploring whether 
first trimester screening for PAS can improve the prenatal diagnostic accuracy and surgical outcome.  
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Figure 1 (A, B,C): Evaluation of the site of implantation of pregnancies after a previous caesarean 
delivery based upon the three suggested methods as well as the combination of all three in a combined 
fashion.  
A: Diagrammatic representation showing the relationships between the gestational sac, previous CS 
and anterior uterine wall (COS insertion). In a sagittal view of the uterus, a straight longitudinal line 
is drawn connecting the internal cervical os and the uterine fundus trough the endometrium 
(endometrial line) (yellow line). Then the gestational sac is identified and its S-I diameter 
perpendicular to the endometrial line traced. According to the relationship between the endometrial 
line and the S-I diameter of the ectopic sac, patients can be divided into two different groups: normal 
pregnancy (a), the gestational sac implant away from the CS, in close proximity to the uterine fundus; 
COS1 insertion (b), gestational sac is implanted within the previous CS and ≥ two thirds of the S-I 
diameter of the gestational sac was above the endometrial line towards the anterior uterine wall; 
COS2+ insertion (c), gestational sac is implanted within the previous CS and < two thirds of the S-I 
diameter of the gestational sac is above the endometrial line; COS2- insertion (d), gestational sac is 
implanted in close proximity of within the previous CS, < two thirds of the S-I diameter of the 
gestational sac is above the endometrial line but there is no intersection between the S-I diameter of 
the ectopic sac and the endometrial line. b: Ultrasound images showing the different types of COS 
insertion (A. Ut. W: anterior uterine wall; B: bladder; C: cervix, CS: caesarean scar; E: endometrium; 
EL: endometrial line; GS: gestational sac; S-I d: superior-inferior diameter; Ut. F: uterine fundus). 
B: The definition of “on the scar” was that the placenta implanted partially or fully on top of a well 
healed scar (1A), while that for “in the niche” was that the placenta implanted into a deficient or 
dehiscent scar (1B). The method of classifying the pregnancy as “in the niche” and “on the scar” was 
also defined numerically as follows: Gestation “on the scar”, when the myometrial thickness between 
the sac and the bladder was ≥3mm.  Gestation “in the niche“, when the myometrium measured ≤2 
mm  
C: Differentiating normal, intrauterine pregnancy implantation from a low, anterior implantation of a 
caesarean scar pregnancy by their sagittal, longitudinal ultrasound picture using “above “ vs “below” 
the line classification. By drawing a perpendicular line to divide uterus in half, location of the centre 
of the gestational sac (X) determines the diagnosis. If the centre of the sac is ABOVE the half line, 
closer to the fundus: it is a normal intrauterine gestation (A).  If the centre of the sac is BELOW the 
half line, closer to the cervix: it’s a CSP (or in rarest of cases, a cervical pregnancy. Clinical 
correlation should always be used!  (Cx: cervix; F: fundus of the uterus). 
 
Figure 2: Receiver operating characteristics curve showing the diagnostic performance different 
types of sonographic first trimester implantation of the gestational sac in predicting PAS3 on 
ultrasound. 
 
Figure 3: Receiver operating characteristics curve showing the diagnostic performance different 
types of sonographic first trimester implantation of the gestational sac in predicting adverse surgical 
outcome. 
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Figure 4: When combining the three different imaging signs of early first trimester assessment of 
gestational sac implantation and placing the defining coordinates of the COS and the “above and 
below the uterine midline” as well as the “on the scar” and “in the niche” on a sagittal US image of 
the uterus, we identified, an area we call “high-risk-for-PAS Triangle”.  If the centre of the gestational 
sac is “in the niche” the pregnancy is high risk for PAS. This diagram enables an easy visual 
perception and application of the three methods to prognosticate the risk for pregnancy outcome.     
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A. Maternal and gestational characteristics:  
  
Mean maternal age in years (SD) 32.8 (5.1) 
Mean gestational age at delivery in weeks (SD) 35.3 (1.7) 
  
Number of previous caesarean deliveries, %, (n)  
- 1 prior CS 29.4 (55) 
- 2 prior CS 44.9 (84) 
- ≥ 3 prior CS 25.7 (48) 
  
Histopathological diagnosis, % (n)  
- Placenta previa without PAS 41.7 (78) 
- Placenta accreta 12.3 (23)  
- Placenta increta 8.6 (16)  
- Placenta percreta 37.4 (70)  
  
  
B: Placenta accreta spectrum disorders stage (US), % (n)  
  
- PAS0 41.7 (78) 
- PAS1 20.9 (39) 
- PAS2 8.6 (16) 
- PAS3 28.9 (54) 
  
C. First trimester ultrasound signs:  
  
Cross-over sign type, % (n)  
- COS0 41.7 (78) 
- COS2 28.9 (54) 
- COS1 29.4 (55) 
  
“In the niche” vs “on the scar” implantation, %, (n)  
- Normal 41.7 (78) 
- “On the scar” 19.3 (36) 
- “In the niche” 39.0 (73) 
  
“Above the line” vs “below the line” implantation  
- “Above the line” 59.9 (112) 
- “Below the line” 40.1 (75) 
  
D. Pregnancy outcome:  
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Composite adverse surgical outcome †, % (n) 11.8 (22) 
Blood loss> 1500 ml, % (n) 6.4 (12) 
Transfusion of units of blood products, % (n) 7.5 (14) 
Admission to ICU, % (n) 8. 6 (16) 
Surgical complication, % (n) 0 (0) 
Estimated blood loss in ml (SD) 788 (428) 
Total units of BP transfused 1.2 (3.5) 
Units of PRBC transfused (SD) 0.51 (1.2) 
Units of FFP transfused (SD) 0.43 (1.4) 
Units of platelets transfused (SD) 0.26 (1.1) 
Operative time (SD) 122.01 (61.9) 
Length of stay in days (SD) 5.23 (2.1) 
SD = Standard deviation; CD = Caesarean delivery;  COS = Cross-over sign;  † 
Combination of: (1) estimated blood loss >1500 mL; (2) transfusion of >5 Units of 
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Table 2. Distribution of different types of implantation assessed at first trimester ultrasound 












COS0 100 (78/78) 0 (0/39)  0 (0/16) 0 (0/54) a, b, c 
COS1 0 (0/78) 7.7 (3/39) 56.3 (9/16) 79.6 (43/54) b, c, d, e 
COS2 0 (0/78) 92.3 (36/39) 43.8 (7/16) 20.4 (11/54) a, b, c, d, e 
 
Normal implantation 100 (78/78) 0 (0/39)  0 (0/16) 0 (0/54) a, b, c 
In the niche 0 (0/78) 23.1 (9/39) 81.3 (13/16) 94.4 (51/54) a, b, c, d, e 
On the scar 0 (0/78) 76.9 (30/39) 18.8 (3/16) 5. 6 (3/54) a, b, d, e 
      
Above the line (78/78) 82.1 (32/39) 12.5 (2/16) 0 (0/54) a, b, c, d, e  
Below the line 0 (0/78) 17.95 (7/39) 87.5 (14/16) 100 (54/54) a, b, c, d, e,   
 
* Chi-squared test. a = p<0.05 for the comparison between women with a diagnosis of PAS0 and women with a diagnosis of PAS1; b = 
p<0.05 for the comparison between women with a diagnosis of PAS0 and women with a diagnosis of PAS2; c = p<0.05 for the 
comparison between women with a diagnosis of PAS0 and women with a diagnosis of PAS3; d: p<0.05 for the comparison between 
women with a diagnosis of PAS1 and women with a diagnosis of PAS2.; e: p<0.05 for the comparison between women with a diagnosis 
of PAS1 and women with a diagnosis of PAS3. f: p<0.05 for the comparison between women with a diagnosis of PAS2 and women 
with a diagnosis of PAS3.   




























Table 3. Logistic regression models evaluating the potential independent 
predictors of a third-trimester diagnosis of PAS-3, and comparison of the 
Receiver Operating Characteristic (ROC) curves of each model 
 
Covariates Adjusted OR 
(95% CI) 
P value 
   
Age, 1-year increase 1.06 (0.93-1.19) 0.4 
   
Gestational age at birth, 1-week increase 0.91 (0.65-1.26) 0.6 
   
Parity, 1-category increase   
- 1 previous birth (ref. cat.) 0 -- 
- 2 previous births 1.52 (0.47-4.99) 0.5 
- ≥3 previous births 2.06 (0.47-9.06) 0.3 
   
Model 1: †   
COS, 1-category increase 7.91 (4.03-15.5) <0.001 
   
Model 2: ¥   
Implantation, "in the niche" vs "on the scar"/normal 29.1 (8.1-104) <0.001 
   
Model 3: §   
Implantation site, below vs above the endometrial 
line 
38.1 (12.0-121) <0.001 
   
† Adjusted for: maternal age, gestational age at delivery, parity, plus COS category.  
¥ Adjusted for maternal age, gestational age at delivery, parity, plus type of implantation. 
§ Adjusted for: maternal age, gestational age at delivery, parity, plus site of implantation. 
Due to a high degree of collinearity across number of previous caesarean sections and parity (spearman’s rho=0.95), 
only the latter covariate was reported in the final models.  
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Table 4. Comparison of maternal and gestational characteristics and first-trimester ultrasound 










    
A. Maternal and gestational characteristics:    
Mean maternal age in years (SD) 35.68 (3.4) 32.38 (5.1) 0.004 
    
Mean gestational age at birth in weeks (SD) 34.07 (1.9) 35.51 (1.6) <0.001 
    
Number of previous caesarean deliveries, % (n)    
- 1 prior CS 18.2 (4) 30.90 (51) 0.319 
- 2 prior CS 40.9 (9) 45.45 (75) 0.821 
    
- ≥ 3 prior CS 40.9 (9) 23.64 (39) 0.116 
Histopathological diagnosis, %    
- Placenta previa without PAS 0 (0) 47.27 (78) <0.001 
- Placenta accreta 0 (0) 13.9 4 (23) 0.081 
- Placenta increta 0 (0) 9.70 (16) 0.224 
- Placenta percreta 100 (22) 29.09 (48) <0.001 
    
B. Ultrasound stage of PAS, % (n)    
- PAS0 0 (0) 47.27 (78) <0.001 
- PAS1 0 (0) 23.64 (39) 0.009 
- PAS2 13.64 (3) 7.88 (13) 0.409 
- PAS3 86.36 (19) 21.21 (35) <0.001 
    
C. First trimester ultrasound signs:    
“Cross-over sign” type, % (n)    
- COS0 0 (0) 47.27 (78) <0.001 
- COS2 9.09 (2) 31.52 (52) 0.042 
- COS1 90.91 (20) 21.21 (35) <0.001 
    
“In the niche/on the scar”, % (n)    
- Normal 0 (0) 47.27 (78) <0.001 
- “On the scar” 4.55 (1) 21.21 (35) 0.083 
- “In the niche” 95.45 (21) 31.51 (52) <0.001 
    
“Above the line/below the line”, % (n)    
- “Above the line” 9.09 (2) 66.67 (110) <0.001 
- “Below the line” 90.91 (20) 33.33 (55) <0.001 
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† Combination of: (1) estimated blood loss >1500 mL; (2) transfusion of >5 Units of blood products; (3) presence of surgical complication; 
(4) admission to Intensive Care Unit. 
* Chi-squared test and Kruskal-Wallis test for categorical and continuous variables, respectively. All p-values that are not indicated were 
>0.05. 
PAS = Placenta accreta spectrum;  SD = Standard deviation;  CS = Cesarean section;  COS = Cross-over sign.  
 
Table 5. Logistic regression models evaluating the potential independent 
predictors of a third-trimester diagnosis of PAS-3, and comparison of the 
Receiver Operating Characteristic (ROC) curves of each model 
 
Covariates Adjusted OR 
(95% CI) 
P value 
   
Age, 1-year increase 1.06 (0.93-1.19) 0.4 
   
Gestational age at birth, 1-week increase 0.91 (0.65-1.26) 0.6 
   
Parity, 1-category increase   
- 1 previous birth (ref. cat.) 0 -- 
- 2 previous births 1.52 (0.47-4.99) 0.5 
- ≥3 previous births 2.06 (0.47-9.06) 0.3 
   
Ultrasound staging of PAS 
PAS3 
4.27 (2.1-17.3) <0.001 
   
Model 1: †   
COS,1 vs COS 2 7.91 (4.03-15.5) <0.001 
   
Model 2: ¥   
"In the niche" vs  
"on the scar"/normal 
29.1 (8.1-79) <0.001 
   
Model 3: §   
Implantation site, “below” vs “above the line” 6.57 (3.9-16.2) <0.001 
   
 
† Adjusted for: maternal age, gestational age at delivery, parity, plus COS category.  
¥ Adjusted for maternal age, gestational age at delivery, parity, plus type of implantation. 
§ Adjusted for: maternal age, gestational age at delivery, parity, plus site of implantation. 
Due to a high degree of collinearity across number of previous caesarean sections and parity (spearman’s rho=0.95), 
only the latter covariate was reported in the final models.  
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Table 6. Diagnostic accuracy of first-trimester ultrasound: (a) different types of cross-over sign (COS); (b) cesarean scar pregnancy variants to predict a 
diagnosis of placenta accreta spectrum (PAS)-3 disorder: summary estimates of sensitivity, specificity, positive and negative predictive values (PPV and 





% (95% CI) 
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% (95% CI) 
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Table 7. Diagnostic accuracy of first-trimester ultrasound: (a) different types of cross-over sign (COS); (b) cesarean scar pregnancy variants to predict 
composite adverse surgical outcome †: summary estimates of sensitivity, specificity, positive and negative predictive values (PPV and NPV), positive 





% (95% CI) 
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† Combination of: (1) estimated blood loss >1500 mL; (2) transfusion of >5 Units of blood products; (3) presence of surgical complication; (4) admission to Intensive Care Unit. 
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Table 8. Differences in surgical outcomes in pregnancies with COS1 implantation in the first 
trimester and PAS3 stage on third trimester ultrasound compared to women with COS2-PAS3. 
 






Composite adverse surgical outcome (%) 44.2 (19) 0 (0) 0.005 
EBL >1.500 ml 23.3 (10) 0 (0) 0.101 
Transfusion of >5 units of BP 23.3 (10) 0 (0) 0101 
Surgical complications 13.95 (6) 18.2 (2) 0.659 
Admission to ICU 0 (0) 0 (0) 1.000 
Estimated blood loss (SD) 1289.07±571.78 935.45±157.25 0.048 
Mean Units of BP transfused (SD) 4.28±6.23 0.36±0.81 0.044 
Mean Units of PRBC transfused (SD) 1.56±1.86 0.18±0.60 0.019 
Mean Units of FFP transfused (SD) 1.65±2.54 0.18±0.60 0.064 
Mean Units of platelets transfused (SD) 1.07±2.15 0±0 0.107 
Length of stay (d) (SD) 6.91±2.11 6.45±1.21 0.492 
Operative time (min) (SD) 182.33±31.08 161.82±32.50 0.058 
Gestational age at Cc (w) (SD) 33.88±1.99 35.05±0.99 0.066 
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